Nephros (NEPH) Interest Coverage Ratio Growth (1y) (2014 - 2026)
Powered by 
Analysis
Nephros (NEPH) Interest Coverage Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | -71.56% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 15.51% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 68.09% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 34.84% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -95.71% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 16.91% |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | 490.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 490.31% |
| Mar 31, 2026 | -76.95% |
| Dec 31, 2025 | -93.97% |
| Sep 30, 2025 | 52.43% |
| Jun 30, 2025 | 176.00% |
| Mar 31, 2025 | 339.46% |
| Dec 31, 2024 | 406.00% |
| Mar 31, 2024 | 98.02% |
| Dec 31, 2023 | 98.68% |
| Mar 31, 2023 | -78.02% |
| Dec 31, 2022 | -124.27% |
| Sep 30, 2022 | -299.31% |
| Jun 30, 2022 | -33.60% |
| Mar 31, 2022 | -119.50% |
| Dec 31, 2021 | -114.88% |
| Sep 30, 2021 | -89.31% |
| Jun 30, 2021 | -90.64% |
| Mar 31, 2021 | -228.19% |
| Dec 31, 2020 | -805.96% |
| Sep 30, 2020 | -192.58% |